SynthesisOrphanet journal of rare diseases2025

Drivers of managed entry agreements to reduce reimbursement challenges of orphan medicinal products: the development of a matrix.

Marcelien H E Callenbach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.